Answers are grounded in this paper and cite their sources.
The CtxB protein is a non-toxic β-subunit of cholera toxin that is responsible for toxin binding to eukaryotic cell receptors. The biological activity and safety of this protein make it suitable for a variety of biomedical applications. In particular, CtxB can act as an adjuvant in mucosal vaccines and is considered for the treatment of some immune pathologies as a modulatory molecule. Here, we investigated the possibility of using a probiotic microorganism to deliver CtxB to the gastrointestinal tract. An expression system for the cholera toxin β-subunit in Escherichia coli M17 cells under the T5 promoter was created. The yield of CtxB upon lactose or IPTG expression induction in vitro exceeded 50 μg per mL of culture per unit of optical density. When orally administered to mice gastrointestinal tract, the induced bacterial culture provoked the development of a pronounced humoral immune response to CtxB.
No takes yet. Share an insight, caveat, or question.
Jamgochian et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: